Title |
Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study
|
---|---|
Published in |
Cancer Epidemiology, Biomarkers & Prevention, March 2007
|
DOI | 10.1158/1055-9965.epi-06-0865 |
Pubmed ID | |
Authors |
Julia A. Knight, Maia Lesosky, Heidi Barnett, Janet M. Raboud, Reinhold Vieth |
Abstract |
Vitamin D, antiproliferative and proapoptotic in breast cancer cell lines, can reduce the development of mammary tumors in carcinogen-exposed rats. Current evidence in humans is limited with some suggestion that vitamin D-related factors may reduce the risk of breast cancer. We conducted a population-based case-control study to assess the evidence for a relationship between sources of vitamin D and breast cancer risk. |
X Demographics
The data shown below were collected from the profiles of 117 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 27 | 23% |
Venezuela, Bolivarian Republic of | 4 | 3% |
India | 3 | 3% |
Australia | 3 | 3% |
United Kingdom | 3 | 3% |
Canada | 3 | 3% |
Turkey | 2 | 2% |
Japan | 2 | 2% |
South Africa | 1 | <1% |
Other | 12 | 10% |
Unknown | 57 | 49% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 98 | 84% |
Practitioners (doctors, other healthcare professionals) | 11 | 9% |
Scientists | 8 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
France | 1 | 1% |
Unknown | 91 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 15 | 16% |
Student > Ph. D. Student | 13 | 14% |
Researcher | 12 | 13% |
Student > Master | 11 | 12% |
Student > Doctoral Student | 7 | 8% |
Other | 23 | 25% |
Unknown | 12 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 33% |
Agricultural and Biological Sciences | 12 | 13% |
Biochemistry, Genetics and Molecular Biology | 11 | 12% |
Nursing and Health Professions | 6 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Other | 12 | 13% |
Unknown | 17 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2024.
All research outputs
#566,531
of 25,591,967 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#213
of 4,856 outputs
Outputs of similar age
#870
of 90,752 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#2
of 51 outputs
Altmetric has tracked 25,591,967 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,856 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.